IP Library Granted Patent US 10,117,882
Granted Patent B2
US 10,117,882 · App. 12/849,950 · Granted Nov 6, 2018

Anti-inflammatory properties of marine lipid compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,117,882
App. No.
12/849,950
Granted
Nov 6, 2018
Kind
B2
Abstract

Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cytokines.

Claims (8)

1. A gel capsule containing a lipid composition comprising a mixture of phospholipid molecules, having the following general structure:

wherein said mixture of phospholipid molecules is characterized in comprising at least 1% docosahexaenoic acid (DHA) residues or eicosopentaenoic acid (EPA) residues at positions R1 or R2 and from 15 to 45% of OH at positions R1 or R2 and wherein R1 and R2 are not simultaneously —OH, wherein R3 is a moiety selected from the group consisting of choline, ethanolamine, inositol and serine moieties, and wherein said mixture of phospholipids is acylated in a range from 55% to about 85%.

2. The composition as claimed in claim 1 , wherein said mixture of phospholipids has a ratio of EPA/DHA ranging from 1:1 to 4:1.

3. The composition of claim 1 , wherein said mixture of phospholipids having a ratio of EPA/DHA ranging from 2:1 to 4:1.

4. The composition of claim 1 , wherein said composition further comprises a lipid carrier in a ratio of from 1:10 to 10:1 to said phospholipids.

5. The composition of claim 4 , wherein said lipid carrier is selected from the group consisting of a triglyceride, a diglyceride, fatty acid ethyl ester, and a fatty acid methyl ester and combinations thereof.

6. The composition of claim 4 , wherein said lipid carrier and said mixture of phospholipids are in a ratio of from about 5:1 to 1:5.

7. The composition of claim 4 , wherein said composition comprises from about 20% to about 90% of said mixture of phospholipids and from about 10% to about 50% of said lipid carrier.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2025
From: AKER BIOMARINE ANTARCTIC AS
To: AKER BIOMARINE HUMAN INGREDIENTS AS
Reel/Frame 072557/0791 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2015
From: TRYGG PHARMA AS
To: AKER BIOMARINE ANTARCTIC AS
Reel/Frame 034976/0791 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2010
From: AKER BIOMARINE ASA
To: TRYGG PHARMA AS
Reel/Frame 024995/0622 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2010
From: BRUHEIM, INGE; BANNI, SEBASTIANO; SAEBO, PER CHRISTIAN; GRIINARI, MIKKO; FUGLSETH, ERIK
To: AKER BIOMARINE ASA
Reel/Frame 024865/0327 →